| Title : Design and synthesis of novel derivatives of the muscarinic agonist tetra(ethylene glycol)(3-methoxy-1,2,5-thiadiazol-4-yl) [3-(1-methyl-1,2,5,6-tetrahydropyrid-3-yl)-1,2,5-thiadiazol-4-yl] ether (CDD-0304): effects of structural modifications on the binding and activity at muscarinic receptor subtypes and chimeras - Tejada_2006_J.Med.Chem_49_7518 |
| Author(s) : Tejada FR , Nagy PI , Xu M , Wu C , Katz T , Dorsey J , Rieman M , Lawlor E , Warrier M , Messer WS, Jr. |
| Ref : Journal of Medicinal Chemistry , 49 :7518 , 2006 |
| Abstract : Tejada_2006_J.Med.Chem_49_7518 |
| ESTHER : Tejada_2006_J.Med.Chem_49_7518 |
| PubMedSearch : Tejada_2006_J.Med.Chem_49_7518 |
| PubMedID: 17149881 |
Tejada FR, Nagy PI, Xu M, Wu C, Katz T, Dorsey J, Rieman M, Lawlor E, Warrier M, Messer WS, Jr. (2006)
Design and synthesis of novel derivatives of the muscarinic agonist tetra(ethylene glycol)(3-methoxy-1,2,5-thiadiazol-4-yl) [3-(1-methyl-1,2,5,6-tetrahydropyrid-3-yl)-1,2,5-thiadiazol-4-yl] ether (CDD-0304): effects of structural modifications on the binding and activity at muscarinic receptor subtypes and chimeras
Journal of Medicinal Chemistry
49 :7518
Tejada FR, Nagy PI, Xu M, Wu C, Katz T, Dorsey J, Rieman M, Lawlor E, Warrier M, Messer WS, Jr. (2006)
Journal of Medicinal Chemistry
49 :7518